# EDGAR Filing Document

**Accession Number:** 0001393584
**File Stem:** 0000950103-23-002244
**Filing Date:** 2023-2
**Character Count:** 20905
**Document Hash:** 0fcea60bf5632426c8437d700c5f1ef4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000950103-23-002244.hdr.sgml**: 20230213

**ACCESSION NUMBER**: 0000950103-23-002244

**CONFORMED SUBMISSION TYPE**: SC 13G/A

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20230213

**DATE AS OF CHANGE**: 20230213

**GROUP MEMBERS**: ROY SCHOENBERG

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** American Well Corp
- **CENTRAL INDEX KEY:** 0001393584
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-BUSINESS SERVICES, NEC [7389]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-92157
- **FILM NUMBER:** 23618212

**BUSINESS ADDRESS:**
- **STREET 1:** 75 STATE STREET
- **STREET 2:** 26TH FLOOR
- **CITY:** Boston
- **STATE:** MA
- **ZIP:** 02109
- **BUSINESS PHONE:** 617-205-3500

**MAIL ADDRESS:**
- **STREET 1:** 75 STATE STREET
- **STREET 2:** 26TH FLOOR
- **CITY:** Boston
- **STATE:** MA
- **ZIP:** 02109
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Schoenberg Ido
- **CENTRAL INDEX KEY:** 0001824129

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A

**MAIL ADDRESS:**
- **STREET 1:** AMERICAN WELL CORPORATION
- **STREET 2:** 75 STATE STREET, 26TH FLOOR
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02109

UNITED STATES<br> SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

**SCHEDULE 13G**

**Under the Securities Exchange Act of 1934**

(Amendment No. 2)\*

---

| |
|:---|
| **American Well Corporation** |
| (Name of Issuer) |
| **Class A Common Stock, par value $0.01 par value per share** |
| (Title of Class of Securities) |
| **03044L105** |
| (CUSIP Number) |
| **December 31, 2022** |
| (Date of Event Which Requires Filing of this Statement) |

---

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☐ Rule 13d-1(c)

☒ Rule
13d-1(d)

\* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

**SCHEDULE 13G**

1 <u> NAME OF REPORTING PERSON OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Ido Schoenberg </u>

2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) (b) ☒ ☐

3 <u>SEC USE ONLY </u> <br> <u>4</u> <u> CITIZENSHIP OR PLACE OF ORGANIZATION Israel </u>

---

| | | |
|:---|:---|:---|
| NUMBER OF <br> SHARES<br> BENEFICIALLY OWNED BY EACH REPORTING PERSON<br> WITH | 5 | SOLE VOTING POWER<br>|
| NUMBER OF <br> SHARES<br> BENEFICIALLY OWNED BY EACH REPORTING PERSON<br> WITH |  |  |
| NUMBER OF <br> SHARES<br> BENEFICIALLY OWNED BY EACH REPORTING PERSON<br> WITH | 6 | SHARED VOTING POWER<br>|
| NUMBER OF <br> SHARES<br> BENEFICIALLY OWNED BY EACH REPORTING PERSON<br> WITH |  | 15851706(1) |
| NUMBER OF <br> SHARES<br> BENEFICIALLY OWNED BY EACH REPORTING PERSON<br> WITH | 7 | SOLE DISPOSITIVE POWER<br>|
| NUMBER OF <br> SHARES<br> BENEFICIALLY OWNED BY EACH REPORTING PERSON<br> WITH |  | 15851706 |
| NUMBER OF <br> SHARES<br> BENEFICIALLY OWNED BY EACH REPORTING PERSON<br> WITH | 8 | SHARED DISPOSITIVE POWER<br>|
| NUMBER OF <br> SHARES<br> BENEFICIALLY OWNED BY EACH REPORTING PERSON<br> WITH |  |  |

---

---

| | |
|:---|:---|
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON<br>15,851,706(1)<br>|

---

---

| | | |
|:---|:---|:---|
| 10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES<br>| ☒ |

---

---

| | |
|:---|:---|
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)<br>6.1%(2)(3)<br>|
| 12 | TYPE OF REPORTING PERSON<br>IN<br>|

---

(1) Consists of (i) 595,232 shares of Class A Common Stock, (ii) 20,311 shares of Class A Common Stock to be issued pursuant to vesting of restricted stock units within 60 days of December 31, 2022, (iii) 13,471,279 shares of Class B Common Stock and (iv) 1,764,884 shares of Class B Common Stock underlying options that are currently exercisable. Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time at the option of the holder thereof. Dr. Ido Schoenberg and Dr. Roy Schoenberg are parties to a voting agreement whereby each has agreed to vote their shares together as a group. Accordingly, each of Dr. Ido Schoenberg and Dr. Roy Schoenberg may be deemed to beneficially own each other's stock with shared voting power, currently consisting in the aggregate of 1,915,989 shares of Class A Common Stock and 30,920,165 shares of Class B Common Stock.

(2) Based on the quotient obtained by dividing (a) the aggregate number of Class A Common Stock and Class B Common Stock, together, beneficially owned by the Reporting Person as set forth in Row 9 by (b) the sum of (i) 244,193,727 shares of Class A Common Stock outstanding as of December 31, 2022 and (ii) the aggregate number of shares of Class B Common Stock beneficially owned by the Reporting Person. The aggregate number of shares of Class B Common Stock beneficially owned by the Reporting Person as set forth in clauses "(a)" and "(b)" of this footnote are treated as converted into shares of Class A Common Stock solely for the purpose of computing the percentage ownership of the Reporting Person.

---

| | |
|:---|:---|
| **CUSIP No. 03044L105**<br>| **SCHEDULE 13G** |

---

(3) Each share of Class A Common Stock is entitled to one vote, and shares of Class B Common Stock will collectively be entitled to a number of votes equal to the product of (x) 1.0408163 and (y) the total number of votes that would be cast at such time by the holders of the Class A and Class C Common Stock and any other preferred stock entitled to vote under the Issuer's certificate of incorporation at such time (resulting in the Class B Common Stock collectively holding 51% of the total outstanding voting power). Accordingly, each of Dr. Ido Schoenberg and Dr. Roy Schoenberg each own 25.5% of the total outstanding voting power, and based on their voting agreement, their interests collectively represent 51% of the aggregate voting power of the Issuer's issued and outstanding share capital.

---

| | |
|:---|:---|
| **CUSIP No. 03044L105**<br>| **SCHEDULE 13G** |

---

1 <u>NAME OF REPORTING PERSON OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Roy Schoenberg </u>

2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) (b) ☒ ☐ <br> 3 <u>SEC USE ONLY</u> <br> 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States

---

| | | |
|:---|:---|:---|
| NUMBER OF <br> SHARES<br> BENEFICIALLY OWNED BY EACH REPORTING PERSON<br> WITH | 5 | SOLE VOTING POWER<br>|
| NUMBER OF <br> SHARES<br> BENEFICIALLY OWNED BY EACH REPORTING PERSON<br> WITH |  |  |
| NUMBER OF <br> SHARES<br> BENEFICIALLY OWNED BY EACH REPORTING PERSON<br> WITH | 6 | SHARED VOTING POWER<br>|
| NUMBER OF <br> SHARES<br> BENEFICIALLY OWNED BY EACH REPORTING PERSON<br> WITH |  | 16984448(1) |
| NUMBER OF <br> SHARES<br> BENEFICIALLY OWNED BY EACH REPORTING PERSON<br> WITH | 7 | SOLE DISPOSITIVE POWER<br>|
| NUMBER OF <br> SHARES<br> BENEFICIALLY OWNED BY EACH REPORTING PERSON<br> WITH |  | 16984448 |
| NUMBER OF <br> SHARES<br> BENEFICIALLY OWNED BY EACH REPORTING PERSON<br> WITH | 8 | SHARED DISPOSITIVE POWER<br>|
| NUMBER OF <br> SHARES<br> BENEFICIALLY OWNED BY EACH REPORTING PERSON<br> WITH |  |  |

---

---

| | |
|:---|:---|
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON<br>16,984,448(1)<br>|

---

---

| | | |
|:---|:---|:---|
| 10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES<br>| ☐ |

---

---

| | |
|:---|:---|
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)<br>6.5%(2)(3)<br>|
| 12 | TYPE OF REPORTING PERSON<br>IN<br>|

---

(1) Consists of (i) 1,280,135 shares of Class A Common Stock, (ii) 20,311 shares of Class A Common Stock to be issued pursuant to vesting of restricted stock units within 60 days of December 31, 2022, (iii) 13,919,118 shares of Class B Common Stock and (iv) 1,764,884 shares of Class B Common Stock underlying options that are currently exercisable. Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time at the option of the holder thereof. Dr. Ido Schoenberg and Dr. Roy Schoenberg are parties to a voting agreement whereby each has agreed to vote their shares together as a group. Accordingly, each of Dr. Ido Schoenberg and Dr. Roy Schoenberg may be deemed to beneficially own each other's stock with shared voting power, currently consisting in the aggregate of 1,915,989 shares of Class A Common Stock and 30,920,165 shares of Class B Common Stock.

(2) Based on the quotient obtained by dividing (a) the aggregate number of Class A Common Stock and Class B Common Stock, together, beneficially owned by the Reporting Person as set forth in Row 9 by (b) the sum of (i) 244,193,727 shares of Class A Common Stock outstanding as of December 31, 2022 and (ii) the aggregate number of shares of Class B Common Stock beneficially owned by the Reporting Person. The aggregate number of shares of Class B Common Stock beneficially owned by the Reporting Person as set forth in clauses "(a)" and "(b)" of this footnote are treated as converted into shares of Class A Common Stock solely for the purpose of computing the percentage ownership of the Reporting Person.

---

| | |
|:---|:---|
| **CUSIP No. 03044L105**<br>| **SCHEDULE 13G** |

---

(3) Each share of Class A Common Stock is entitled to one vote, and shares of Class B Common Stock will collectively be entitled to a number of votes equal to the product of (x) 1.0408163 and (y) the total number of votes that would be cast at such time by the holders of the Class A and Class C Common Stock and any other preferred stock entitled to vote under the Issuer's certificate of incorporation at such time (resulting in the Class B Common Stock collectively holding 51% of the total outstanding voting power). Accordingly, each of Dr. Ido Schoenberg and Dr. Roy Schoenberg each own 25.5% of the total outstanding voting power, and based on their voting agreement, their interests collectively represent 51% of the aggregate voting power of the Issuer's issued and outstanding share capital.

---

| | |
|:---|:---|
| **CUSIP No. 03044L105**<br>| **SCHEDULE 13G** |

---

Item 1. (a) NAME OF ISSUER

American Well Corporation (the "Company")

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES

75 State Street

26th Floor

Boston, MA 02109

Item 2. (a) NAMES OF PERSONS FILING

This Statement is being filed on behalf of each of the following persons (collectively, the "Reporting Persons"):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Ido
 Schoenberg

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Roy
 Schoenberg

The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed with this Schedule 13G as Exhibit 99.1, pursuant to which the Reporting Persons have agreed to file this Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) of the Act.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) ADDRESS OF PRINCIPAL BUSINESS OFFICE

The principal addresses of the Reporting Persons are as follows:

75 State Street

26th Floor

Boston, MA 02109

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) CITIZENSHIP

(i) Ido
 Schoenberg – Israel

(ii) Roy
 Schoenberg – United States

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) TITLE OF CLASS OF SECURITIES

Class A common stock, par value $0.01 per share (the "Shares")

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) CUSIP NUMBER

03044L105

---

| | |
|:---|:---|
| **CUSIP No. 03044L105**<br>| **SCHEDULE 13G** |

---

Item 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13d-1(b) OR 13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS:

Not applicable.

Item 4. OWNERSHIP.

&nbsp;&nbsp;&nbsp;&nbsp;(a) <u>Amount Beneficially Owned as of December 31, 2022</u>:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Ido Schoenberg: 15,851,706 Shares (1)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Roy Schoenberg: 16,984,448 Shares (2)

&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>Percentage Owned</u>:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Ido Schoenberg: 6.1% (3)(4)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Roy Schoenberg: 6.5% (3)(4)

&nbsp;&nbsp;&nbsp;&nbsp;(c) <u>Number of Shares as to Which Such Person Has</u>:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) sole power to vote or direct the vote of

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A) Ido Schoenberg: 0

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B) Roy Schoenberg: 0

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) shared power to vote or direct the vote of

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A) Ido Schoenberg: 15,851,706 (1)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B) Roy Schoenberg: 16,984,448 (2)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) sole power to dispose or to direct the disposition of

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A) Ido Schoenberg: 15,851,706

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B) Roy Schoenberg: 16,984,448

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) shared power to dispose or to direct the disposition of

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A) Ido Schoenberg: 0

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B) Roy Schoenberg: 0

<u>Notes</u>:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Consists
 of (i) 595,232 shares of Class A Common Stock, (ii) 20,311 shares of Class A Common Stock
 to be issued pursuant to vesting of restricted stock units within 60 days of December 31,
 2022, (iii) 13,471,279 shares of Class B Common Stock and (iv) 1,764,884 shares of Class
 B Common Stock underlying options that are currently exercisable. Each share of Class B Common
 Stock is convertible into one share of the Issuer's Class A Common Stock at any time
 at the option of the holder thereof. Dr. Ido Schoenberg and Dr. Roy Schoenberg are parties
 to a voting agreement whereby each has agreed to vote their shares together as a group. Accordingly,
 each of Dr. Ido Schoenberg and Dr. Roy Schoenberg may be deemed to beneficially own each
 other's stock with shared voting power, currently consisting in the aggregate of 1,915,989
 shares of Class A Common Stock and 30,920,165 shares of Class B Common Stock.

---

| | |
|:---|:---|
| **CUSIP No. 03044L105**<br>| **SCHEDULE 13G** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Consists
 of (i) 1,280,135 shares of Class A Common Stock, (ii) 20,311 shares of Class A Common Stock
 to be issued pursuant to vesting of restricted stock units within 60 days of December 31,
 2022, (iii) 13,919,118 shares of Class B Common Stock and (iv) 1,764,884 shares of Class
 B Common Stock underlying options that are currently exercisable. Each share of Class B Common
 Stock is convertible into one share of the Issuer's Class A Common Stock at any time
 at the option of the holder thereof. Dr. Ido Schoenberg and Dr. Roy Schoenberg are parties
 to a voting agreement whereby each has agreed to vote their shares together as a group. Accordingly,
 each of Dr. Ido Schoenberg and Dr. Roy Schoenberg may be deemed to beneficially own each
 other's stock with shared voting power, currently consisting in the aggregate of 1,915,989
 shares of Class A Common Stock and 30,920,165 shares of Class B Common Stock.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) Based
 on the quotient obtained by dividing (a) the aggregate number of Class A Common Stock and
 Class B Common Stock, together, beneficially owned by the Reporting Person as set forth in
 Row 9 by (b) the sum of (i) 244,193,727 shares of Class A Common Stock outstanding as of
 December 31, 2022, and (ii) the aggregate number of shares of Class B Common Stock beneficially
 owned by the Reporting Person. The aggregate number of shares of Class B Common Stock beneficially
 owned by the Reporting Person as set forth in clauses "(a)" and "(b)"
 of this footnote are treated as converted into shares of Class A Common Stock solely for
 the purpose of computing the percentage ownership of the Reporting Person.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) Each
 share of Class A Common Stock is entitled to one vote, and shares of Class B Common Stock
 will collectively be entitled to a number of votes equal to the product of (x) 1.0408163
 and (y) the total number of votes that would be cast at such time by the holders of the Class
 A and Class C Common Stock and any other preferred stock entitled to vote under the Issuer's
 certificate of incorporation at such time (resulting in the Class B Common Stock collectively
 holding 51% of the total outstanding voting power). Accordingly, each of Dr. Ido Schoenberg
 and Dr. Roy Schoenberg each own 25.5% of the total outstanding voting power, and based on
 their voting agreement, their interests collectively represent 51% of the aggregate voting
 power of the Issuer's issued and outstanding share capital.

### Item 5. OWNERSHIP
 OF FIVE PERCENT OR LESS OF A CLASS
Not applicable.

### Item 6. OWNERSHIP
 OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
Not applicable.

Item 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY

Not applicable.

Item 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP

See Item 4, which states the identity of the members of the group filing this Schedule 13G.

Item 9. NOTICE OF DISSOLUTION OF GROUP

Not applicable.

Item 10. CERTIFICATION

Not applicable.

**SCHEDULE 13G**

**Exhibit Index**

Exhibit 99.1. Joint Filing Agreement as required by Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.

**SIGNATURES**

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated as of February 13, 2023

---

| | |
|:---|:---|
| **IDO SCHOENBERG** | **IDO SCHOENBERG** |
| By: | /s/ Ido Schoenberg |
| **ROY SCHOENBERG** | **ROY SCHOENBERG** |
| By: | /s/ Roy Schoenberg |

---

[*Signature Page to Schedule 13G*]

## Exhibit 99.1

**Exhibit 99.1**

**JOINT FILING AGREEMENT**

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to (i) this joint filing on behalf of each of them of a statement on Schedule 13G (including any amendments thereto) with respect to the Class A Common Stock of American Well Corporation, par value $0.01 per share, and (ii) that this Joint Filing Agreement be included as an exhibit to such joint filing, provided that, as contemplated by Section 13d-1(k)(ii), no person shall be responsible for the completeness and accuracy of the information concerning the other person making the filing unless such person knows or has reason to believe such information is inaccurate.

This Joint Filing Agreement may be executed in any number of counterparts all of which together shall constitute one and the same instrument.

---

| | |
|:---|:---|
| **IDO SCHOENBERG** | **IDO SCHOENBERG** |
| By: | /s/ Ido Schoenberg |
| **ROY SCHOENBERG** | **ROY SCHOENBERG** |
| By: | /s/ Roy Schoenberg |

---

[*Signature Page to Joint Filing Agreement - Schedule 13G*]